Related Experiment Video
Updated: Apr 16, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS
Maria Teresa Carrì1, Cristiana Valle2, Francesca Bozzo1
1Department of Biology, Università di Roma Tor Vergata Rome, Italy ; Fondazione Santa Lucia, IRCCS Rome, Italy.
Abstract:
It is well known that mitochondrial damage (MD) is both the major contributor to oxidative stress (OS) (the condition arising from unbalance between production and removal of reactive oxygen species) and one of the major consequences of OS, because of the high dependance of mitochondrial function on redox-sensitive targets such as intact membranes. Conditions in which neuronal cells are not able to cope with MD and OS seem to lead or contribute to several neurodegenerative diseases including Amyotrophic Lateral Sclerosis (ALS), at least in the most studied superoxide dismutase 1 (SOD1)-linked genetic variant. As summarized in this review, new evidence indicates that MD and OS play a role also in non-SOD1 ALS and thus they may represent a target for therapy despite previous failures in clinical trials.
Insights
Mitochondrial damage and oxidative stress are implicated in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS). New evidence suggests they are key factors in non-SOD1 ALS, offering potential therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mitochondrial damage (MD) is a major contributor to and consequence of oxidative stress (OS).
- Mitochondrial function relies on redox-sensitive targets, making it vulnerable to OS.
- Inability of neuronal cells to manage MD and OS contributes to neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS).
Purpose of the Study:
- To review the role of mitochondrial damage and oxidative stress in Amyotrophic Lateral Sclerosis (ALS).
- To explore the potential of targeting MD and OS for ALS therapy.
Main Methods:
- Literature review of existing evidence on MD, OS, and ALS.
- Analysis of studies focusing on SOD1-linked ALS and non-SOD1 ALS.
Main Results:
- MD and OS are established factors in SOD1-linked ALS.
- Emerging evidence implicates MD and OS in non-SOD1 ALS pathogenesis.
- Previous therapeutic attempts targeting these pathways have faced challenges.
Conclusions:
- Mitochondrial damage and oxidative stress are significant factors in various forms of ALS.
- Despite past clinical trial failures, targeting MD and OS remains a promising therapeutic avenue for ALS.
- Further research is warranted to develop effective therapies for ALS based on MD and OS pathways.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

